NICE makes major changes to type 2 diabetes treatment
By Liz Wells 20 February 2026
New NICE guidance will see millions of diabetes patients will get access to medicines that protect the heart and kidneys, while NHS savings of £560m from using generic dapagliflozin.
Most Read News
- Virtual ward study finds no impact on hospital admissions
- BREAKING NEWS: Northern Care Alliance declares critical incident over strike action
- PocDoc partners with Thames Valley GP practice on cardiovascular disease
- Slower recruitment and hospital activity growth help slash NHS top-up
- Leadership stability makes a difference at Gloucestershire Hospitals
Most Read News
- Virtual ward study finds no impact on hospital admissions
- BREAKING NEWS: Northern Care Alliance declares critical incident over strike action
- PocDoc partners with Thames Valley GP practice on cardiovascular disease
- Slower recruitment and hospital activity growth help slash NHS top-up
- Leadership stability makes a difference at Gloucestershire Hospitals
©2026 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
